| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.049 | 0.4 |